New therapies, combinations improving myeloma survival; more on the way
This article was originally published in Scrip
Executive Summary
Genomic research is under way to increase survival beyond the gains already seen in multiple myeloma during the past few decades, but the drug development pipeline is teeming with new therapies and combination regimens that are improving remission rates.